Claire Seedhouse - Concepedia

Author

Claire Seedhouse

Also Known As

C H Seedhouse, C Seedhouse, C. H. Seedhouse, C. Seedhouse, C.H. Seedhouse, Claire H Seedhouse, Claire H. Seedhouse, Claire Helen Seedhouse, Claire Seedhouse, Seedhouse, C

125

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

University of Nottingham Nottingham University Hospitals NHS Trust Nottingham City Hospital Nottingham Trent University National University of Malaysia

About

Claire Seedhouse is an author at University of Nottingham specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	18	875
2	Health Sciences	6	6	165
3	Natural Sciences	3	3	216
4	Public Health	1	1	16
5	Allergy	1	1	25

Claire Seedhouse

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
The genotype distribution of the XRCC1gene indicates a role for base excision repair in the development of therapy-related acute myeloblastic leukemia Claire Seedhouse, Rowena D. Bainton, Michael D. Lewis, Blood	2002	177
Polymorphisms in Genes Involved in Homologous Recombination Repair Interact to Increase the Risk of Developing Acute Myeloid Leukemia Claire Seedhouse, Rowena D. Faulkner, Nadia Ashraf, Clinical Cancer Research	2004	166
Targeting XRCC1 Deficiency in Breast Cancer for Personalized Therapy Rebeka Sultana, Tarek M.A. Abdel-Fatah, Rachel Abbotts, Cancer Research Breast OncologyMedicineXrcc1 ExpressionPathologyCancer Cell Biology	2012	96
Synthetic lethal targeting of DNA double‐strand break repair deficient cells by human apurinic/apyrimidinic endonuclease inhibitors Rebeka Sultana, Daniel R. McNeill, Rachel Abbotts, International Journal of Cancer Tumor BiologyGenome InstabilityDna DamageNovel TherapyOncogenic Agent	2012	94
Vascular Endothelial Growth Factor Induction by Prostaglandin E2 in Human Airway Smooth Muscle Cells Is Mediated by E Prostanoid EP2/EP4 Receptors and SP-1 Transcription Factor Binding Sites Dawn A. Bradbury, Deborah Clarke, Claire Seedhouse, Journal of Biological Chemistry Inflammatory Lung DiseaseCellular PhysiologyPge2-induced Luciferase ActivityInflammationTranscriptional Regulation	2005	91
Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Protein Kinase Inhibition Is Synthetically Lethal in XRCC1 Deficient Ovarian Cancer Cells Rebeka Sultana, Tarek M.A. Abdel-Fatah, Christina J. Perry, PLoS ONE	2013	83
DNA repair contributes to the drug-resistant phenotype of primary acute myeloid leukaemia cells with FLT3 internal tandem duplications and is reversed by the FLT3 inhibitor PKC412 Claire Seedhouse, Hannah Hunter, Bethan Lloyd‐Lewis, Leukemia Hematological MalignancyGenome InstabilityDrug-resistant PhenotypeMixed-phenotype Acute LeukemiaGenetics	2006	81
Targeting BRCA1‐BER deficient breast cancer by ATM or DNA‐PKcs blockade either alone or in combination with cisplatin for personalized therapy Nada Albarakati, Tarek M.A. Abdel-Fatah, Rachel Doherty, Molecular Oncology	2014	79
Up-regulation of genes involved in the insulin signalling pathway (IGF1, PTEN and IGFBP1) in the endometrium may link polycystic ovarian syndrome and endometrial cancer Mohamad Nasir Shafiee, Claire Seedhouse, Nigel P. Mongan, Molecular and Cellular Endocrinology Polycystic Ovarian SyndromeGynecologyPathologyPolycystic Ovary SyndromeMenstrual Cycle	2016	75
Clinicopathological and functional significance of XRCC1 expression in ovarian cancer Tarek M.A. Abdel-Fatah, Rebeka Sultana, Rachel Abbotts, International Journal of Cancer Xrcc1 Protein ExpressionOncologyMalignant DiseaseOncogenic AgentMedicine	2012	64

Page 1